Baissier
Salesforce (CRM) stock declines 2% amid AI competition and contract cancellations
Ce briefing n’est pas encore disponible dans cette langue — version anglaise affichée.
In the past 24 hours, Salesforce's stock fell 2%, closing at $170.37. This decline is attributed to increased competition from lower-cost AI sales tools and the cancellation of a significant contract by Curative, highlighting potential challenges in customer retention.
Points clés
- Salesforce shares dropped 2% on July 21, 2026, closing at $170.37.
- Curative canceled a $600,000 annual Salesforce contract after developing its own AI-driven CRM solution.
- Morgan Stanley maintained an 'equal weight' rating on Salesforce, lowering the price target to $185 from $287.
- Analysts continue to rate Salesforce as a 'Moderate Buy,' with an average price target of $249.51, suggesting potential upside from current levels.
Sources
- Salesforce (NYSE:CRM) Trading Down 2% - Here's What HappenedMarketBeat · July 21, 2026
- Salesforce's (CRM) Equal Weight Rating Reiterated at Morgan StanleyMarketBeat · July 21, 2026
- Salesforce (NYSE:CRM) Shares Gap Down - Time to Sell?MarketBeat · July 21, 2026
- Salesforce Cratered 33% in 2026. One Analyst Sees It Exploding Nearly 200%24/7 Wall St. · July 21, 2026
Généré par IA à partir de sources d'actualités publiques. Ceci n'est pas un conseil financier.
